Integration of AI in Medical Communications: A Roadmap
AI in medical communications: Why it matters now Artificial intelligence (AI) is rapidly reshaping medical communications (MedComms), driven by the necessity for personalization, efficiency, and speed in content delivery. As pharmaceutical companies face mounting competition, the demand for innovative communication strategies to communicate complex data and information, as early as the critical pre-launch phase, is…...
Read MoreTop Stories
The Nelson Memo: Igniting a Global Open Data
The landscape of scientific research is undergoing a seismic...
Rare Diseases – An Evolving Medical
A disease is considered rare when it affects fewer than 1 in...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Filter
MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches
At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered...
It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with...
MedTech Summit 2021: Understanding Post Market Clinical Follow Up (PCMF)
An ideal PMCF plan, with reference to MDCG 2020-7, presents the general and specific methods...
Bringing New Devices to Market under the EU MDR
With the MDR coming into effect, the manufacturers should plan and construct their strategy to...
A Summarized Report of the Virtual MedTech EU MDR Exchange Conference
Session summaries from EUMDR exchange conference 2021...
Digital Therapeutics and Medical Communications: Are We Ready?
Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...
- 1
- 2